Findings

What do systematic reviews say?

14 questions · 14 findings · 2 reviews · Common Mental Disorders

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 5 · 35.7%Low 9 · 64.3%Moderate 0 · 0%High 0 · 0%

DANCE THERAPY vs Waitlist/Usual Care

Depression score SCL‐90‐R depression sub‐scale (13 items); HAM‐D. Scale from: 0 to 84 (HAM‐D) or 52 (SCL‐90‐R depression sub‐scale). · patients with depression

1 finding from 1 review

Dance movement therapy for depression 2015 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 147 participants
Very low

DANCE THERAPY vs Waitlist/Usual Care

Total number of drop‐outs · patients with depression

Dance Movement Therapy (DMT) showed no clear difference in drop‐outs drop‐out numbers in each arm compared with standard care or waiting list control (low certainty).

1 finding from 1 review

Dance movement therapy for depression 2015 · Cochrane Headline outcomes only
OR 1.82 [0.35, 9.45]
1 study · 31 participants
Low

DANCE THERAPY vs Waitlist/Usual Care

Social and occupational functioning · patients with depression

1 finding from 1 review

Dance movement therapy for depression 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Very low

DANCE THERAPY vs Waitlist/Usual Care

Quality of Life Manchester Short Assessment (MANSA) · patients with depression

1 finding from 1 review

Dance movement therapy for depression 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 22 participants
Low

DANCE THERAPY vs Waitlist/Usual Care

Self-esteem (Piers-Harris self-concept scale) · patients with depression

1 finding from 1 review

Dance movement therapy for depression 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 21 participants
Low

Levetiracetam vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 16 participants
Very low

Benzodiazepines vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 75 participants
Low

MAOIs vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 51 participants
Very low

Comparison 1: 5HT1A partial agonists vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Very low

Comparison 9: NaSSAs vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Low

Comparison 10: RIMAs vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 695 participants
Low

Comparison 12: SNRIs vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 261 participants
Low

Comparison 13: SSRIs vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 1173 participants
Low

Comparison 2: anticonvulsants/GABAs vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 69 participants
Low